Guardant Health Inc (NASDAQ: GH) is 37.19% higher on its value in year-to-date trading and has touched a low of $15.81 and a high of $38.53 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GH stock was last observed hovering at around $38.11 in the last trading session, with the day’s loss setting it -1.0%.
Currently trading at $37.11, the stock is 14.51% and 42.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.5 million and changing -2.62% at the moment leaves the stock 48.41% off its SMA200. GH registered 37.80% gain for a year compared to 6-month loss of 27.88%. The firm has a 50-day simple moving average (SMA 50) of $25.778 and a 200-day simple moving average (SMA200) of $24.93215.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 57.78% gain in the last 1 month and extending the period to 3 months gives it a 56.38%, and is 5.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.42% over the week and 5.87% over the month.
Guardant Health Inc (GH) has around 1779 employees, a market worth around $4.59B and $692.26M in sales. Profit margin for the company is -74.02%. Distance from 52-week low is 134.72% and -3.69% from its 52-week high. The company has generated returns on investments over the last 12 months (-40.93%).
The EPS is expected to grow by 19.46% this year
385.0 institutions hold shares in Guardant Health Inc (GH), with institutional investors hold 110.43% of the company’s shares. The shares outstanding are 123.16M, and float is at 117.83M with Short Float at 7.97%. Institutions hold 105.38% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5609 of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.2332 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 5.0063 and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6973 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Joyce Meghan V., the company’s Director. SEC filings show that Joyce Meghan V. sold 100 shares of the company’s common stock on Dec 02 ’24 at a price of $35.90 per share for a total of $3590.0. Following the sale, the insider now owns 7548.0 shares.
Still, SEC filings show that on Nov 18 ’24, Kalia Kumud (Chief Information Officer) disposed off 7,000 shares at an average price of $29.25 for $0.2 million. The insider now directly holds 17,744 shares of Guardant Health Inc (GH).
